| Primary |
| Pulmonary Arterial Hypertension |
36.8% |
| Product Used For Unknown Indication |
30.8% |
| Pulmonary Hypertension |
20.3% |
| Scleroderma |
2.3% |
| Cor Pulmonale Chronic |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Connective Tissue Disorder |
0.8% |
| Hypertension |
0.7% |
| Portopulmonary Hypertension |
0.6% |
| Sleep Apnoea Syndrome |
0.6% |
| Heart Disease Congenital |
0.6% |
| Pulmonary Fibrosis |
0.6% |
| Interstitial Lung Disease |
0.6% |
| Essential Hypertension |
0.5% |
| Systemic Lupus Erythematosus |
0.5% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Sarcoidosis |
0.4% |
| Cardiac Failure Congestive |
0.4% |
| Asthma |
0.4% |
| Hiv Infection |
0.4% |
|
| Death |
30.6% |
| Pneumonia |
11.7% |
| Dyspnoea |
8.7% |
| Unevaluable Event |
5.3% |
| Oedema Peripheral |
4.3% |
| Pulmonary Arterial Hypertension |
3.7% |
| Respiratory Failure |
3.6% |
| Syncope |
3.5% |
| Oedema |
3.5% |
| Pulmonary Hypertension |
3.1% |
| Fluid Retention |
2.8% |
| Local Swelling |
2.5% |
| Cardiac Failure Congestive |
2.5% |
| Swelling |
2.5% |
| Nasal Congestion |
2.2% |
| Renal Failure |
2.1% |
| Weight Increased |
2.0% |
| Right Ventricular Failure |
1.8% |
| Malaise |
1.8% |
| Vomiting |
1.8% |
|
| Secondary |
| Pulmonary Hypertension |
40.6% |
| Pulmonary Arterial Hypertension |
12.3% |
| Scleroderma |
7.7% |
| Chronic Obstructive Pulmonary Disease |
5.6% |
| Sleep Apnoea Syndrome |
4.5% |
| Product Used For Unknown Indication |
4.0% |
| Connective Tissue Disorder |
3.1% |
| Interstitial Lung Disease |
2.7% |
| Heart Disease Congenital |
2.5% |
| Pulmonary Fibrosis |
2.3% |
| Unevaluable Event |
2.0% |
| Sarcoidosis |
1.6% |
| Cardiac Failure Congestive |
1.6% |
| Systemic Lupus Erythematosus |
1.6% |
| Cor Pulmonale Chronic |
1.4% |
| Lung Disorder |
1.3% |
| Diastolic Dysfunction |
1.3% |
| Hypoxia |
1.3% |
| Pulmonary Embolism |
1.3% |
| Rheumatoid Arthritis |
1.3% |
|
| Pneumonia |
14.1% |
| Dyspnoea |
12.7% |
| Death |
12.5% |
| Respiratory Failure |
9.0% |
| Pulmonary Hypertension |
5.7% |
| Unevaluable Event |
4.6% |
| Pulmonary Arterial Hypertension |
4.5% |
| Syncope |
4.5% |
| Oedema Peripheral |
3.6% |
| Right Ventricular Failure |
3.6% |
| Fluid Retention |
3.4% |
| Oedema |
3.2% |
| Renal Failure |
3.2% |
| Cardiac Failure Congestive |
2.7% |
| Lung Disorder |
2.7% |
| Liver Function Test Abnormal |
2.2% |
| Pulmonary Fibrosis |
2.2% |
| Swelling |
2.1% |
| Vomiting |
1.9% |
| Weight Increased |
1.9% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
53.6% |
| Product Used For Unknown Indication |
13.6% |
| Pulmonary Hypertension |
9.3% |
| Cor Pulmonale Chronic |
9.2% |
| Drug Use For Unknown Indication |
3.4% |
| Hypertension |
1.0% |
| Pain |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Depression |
0.8% |
| Raynaud's Disease |
0.8% |
| Scleroderma |
0.8% |
| Systemic Sclerosis |
0.8% |
| Arthralgia |
0.7% |
| Cardiac Disorder |
0.7% |
| Diuretic Therapy |
0.7% |
| Diabetes Mellitus |
0.6% |
| Hiv Infection |
0.6% |
| Osteoporosis |
0.6% |
| Promotion Of Peripheral Circulation |
0.6% |
| Anticoagulant Therapy |
0.5% |
|
| Death |
26.4% |
| Pneumonia |
11.7% |
| Dyspnoea |
7.7% |
| Vomiting |
7.4% |
| Pulmonary Arterial Hypertension |
5.0% |
| Syncope |
5.0% |
| Fluid Retention |
4.0% |
| Interstitial Lung Disease |
3.3% |
| Pulmonary Oedema |
3.3% |
| Right Ventricular Failure |
3.3% |
| Device Related Infection |
2.7% |
| Loss Of Consciousness |
2.7% |
| Diarrhoea |
2.3% |
| Fatigue |
2.3% |
| Haemorrhage |
2.3% |
| Pulmonary Hypertension |
2.3% |
| Chest Pain |
2.0% |
| Hypoxia |
2.0% |
| Infusion Site Infection |
2.0% |
| Pyrexia |
2.0% |
|
| Interacting |
| Pulmonary Arterial Hypertension |
100.0% |
|
|
